XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Basis of Presentation - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Oct. 23, 2025
Sep. 11, 2024
Feb. 25, 2024
Sep. 30, 2024
Feb. 29, 2024
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Oct. 31, 2025
Oct. 10, 2025
Sep. 11, 2025
Jul. 31, 2025
Subsidiary, Sale of Stock [Line Items]                            
Accumulated Deficit           $ 298,683,000   $ 298,683,000   $ 268,195,000        
Net cash used in operating activities               (10,340,000) $ (14,215,000)          
Cash and cash equivalents       $ 21,582,000   $ 23,760,000 $ 21,582,000 $ 23,760,000 $ 21,582,000 $ 20,331,000        
Common stock, par value (in dollars per share)           $ 0.0001   $ 0.0001   $ 0.0001        
Extension period (in days)                           90 days
Subsequent Event                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock, par value (in dollars per share)                       $ 0.0001    
WTI Loan Facility | Term Loan                            
Subsidiary, Sale of Stock [Line Items]                            
Term loan facility   $ 15,000,000                        
Extension period (in days)                           90 days
WTI Loan Facility | Term Loan | First Tranche Commitment                            
Subsidiary, Sale of Stock [Line Items]                            
Term loan facility   10,000,000                        
Proceeds from long-term borrowings       7,500,000                    
ABL Line of Credit | Line of Credit | Revolving Credit Facility                            
Subsidiary, Sale of Stock [Line Items]                            
Maximum borrowing capacity   $ 15,000,000                     $ 20,000,000  
Additional maximum borrowing capacity                         $ 5,000,000  
Three Largest Customers | Customer Concentration Risk | Accounts Receivable                            
Subsidiary, Sale of Stock [Line Items]                            
Concentration risk percentage               69.00%   63.00%        
Customer 1 | Customer Concentration Risk | Revenue Benchmark                            
Subsidiary, Sale of Stock [Line Items]                            
Concentration risk percentage           37.00% 50.00% 46.00% 40.00%          
Customer 1 | Customer Concentration Risk | Accounts Receivable                            
Subsidiary, Sale of Stock [Line Items]                            
Concentration risk percentage               40.00%            
Customer 2 | Customer Concentration Risk | Revenue Benchmark                            
Subsidiary, Sale of Stock [Line Items]                            
Concentration risk percentage           10.00%     12.00%          
Customer 3 | Customer Concentration Risk | Revenue Benchmark                            
Subsidiary, Sale of Stock [Line Items]                            
Concentration risk percentage           10.00%                
September 2024 Offering                            
Subsidiary, Sale of Stock [Line Items]                            
Sale of stock, shares issued in transaction (in shares)   3,135,136                        
Net proceeds from Initial Public Offering and Private Placement per unit (in dollars per share)   $ 3.70                        
Proceeds received from issuance of common stock       $ 10,590,000                    
September 2024 Offering | Subsequent Event                            
Subsidiary, Sale of Stock [Line Items]                            
Sale of stock, shares issued in transaction (in shares) 4,825,400                          
Net proceeds from Initial Public Offering and Private Placement per unit (in dollars per share)                     $ 7.15      
Private Placement                            
Subsidiary, Sale of Stock [Line Items]                            
Sale of stock, shares issued in transaction (in shares)   750,000                        
Series B Convertible Preferred Stock | Private Placement                            
Subsidiary, Sale of Stock [Line Items]                            
Common stock, par value (in dollars per share)     $ 0.0001                      
Proceeds from issuance of preferred stock     $ 9,250,000   $ 9,250,000